[시장보고서]천골신경조절술 시장 : 제품 종류별, 용도별, 최종사용자별, 환자 연령층별, 기술별, 국가별, 지역별

천골신경조절술 시장 : 제품 종류별, 용도별, 최종사용자별, 환자 연령층별, 기술별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Sacral Neuromodulation Market, By Product Type, By Application, By End User, By Patient Age Group, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

상품코드 : 1944417

리서치사 : AnalystView Market Insights

발행일 : 2026년 02월

페이지 정보 : 영문 374 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,250

￦ 4,882,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650

￦ 6,986,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650

￦ 8,488,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

천골신경조절술 시장 규모는 2024년에 19억 8,787만 달러로 평가되었으며, 2025년부터 2032년까지 CAGR 11.51%로 확대될 전망입니다.

천골신경조절술(SNM)은 전기 펄스를 이용하여 천골신경을 자극하는 의료 치료법입니다. 이 치료법은 골반 내 장기와 뇌 사이에 존재하는 비정상적인 신경 신호를 치료하여 정상적인 신경 기능을 회복시키는 치료법입니다. 의사는 행동요법이나 약물요법 등 표준치료에 반응하지 않는 과민성 방광, 절박성 요실금, 비폐색성 요폐, 변실금 환자에게 천골신경조절술을 적용합니다. 치료는 시험 단계부터 시작되며, 시험 자극을 통해 환자의 반응을 모니터링한 후 증상이 크게 호전된 환자에게 영구적인 신경자극기를 이식합니다.

천골신경조절술의 시장 역학

인지도 향상 및 상환 경로 개선

천골신경조절술 시장은 크게 두 가지 요인에 의해 성장하고 있습니다. 의사와 환자에 대한 교육이 강화되면서 방광 및 장질환에 대한 신경조절요법의 조기 진단과 수용이 늘어난 것이 그 배경입니다. 임상 교육 프로그램의 확대와 임상적 근거의 강화, 그리고 비뇨기과 및 소화기과 치료 가이드라인에 천골신경조절술이 채택되면서 의사의 신뢰도와 의뢰율이 향상되었습니다. 북미 및 일부 유럽 시장에서의 명확한 상환 프레임워크와 보험 적용 범위 확대가 결합되어 환자가 기기 이식 및 후속 치료에 대해 부담해야 하는 경제적 부담이 줄어들었습니다. 향상된 인지도와 더 나은 상환 시스템의 조합은 환자의 치료 접근성을 개선하고 난치성 질환에 대한 표준 치료로서 천골신경조절술의 채택을 가속화하여 시장의 지속적인 성장을 촉진하고 있습니다.

천골신경조절술 시장 : 세분화 분석

제품 종류별

예측 기간 동안 이식형 펄스 발생 장치(IPG) 부문이 시장을 주도할 것으로 예상됩니다. 천골신경조절술 시스템은 천골 신경에 직접 연결하여 골반저 장애를 치료하는 제어된 전기 펄스를 제공하는 IPG에 의존합니다. IPG 장치는 치료 작업의 필수 구성요소로 작용하여 시장 수요와 천골신경조절술 치료의 채택 사이에 직접적인 연관성을 창출하고 있습니다. 이를 통해 업계 시장 전체에서 막대한 수익을 창출하고 있습니다. 소형화 설계, 장수명 배터리, MRI 지원, 프로그램 기능 등 기술 개발의 발전으로 IPG는 환자와 의사 모두에게 더욱 유용하게 사용되고 있습니다. 이러한 개선은 환자의 편의성 향상으로 이어져 임상 결과의 개선으로 이어집니다. 이 효과로 인해 사용률과 제품 재구매율이 모두 증가했습니다.

천골신경조절술 시장 - 지역별 분석

예측 기간 동안 북미가 천골신경조절술 시장을 주도할 것으로 예상됩니다. 성장의 주요 원인은 요실금, 변실금 등 골반저 질환의 높은 발생률에 있으며, 이로 인해 효과적인 신경조절치료에 대한 지속적인 수요가 발생하고 있습니다. 이 지역은 탄탄한 의료 네트워크의 혜택을 누리고 있으며, 천골신경자극술과 같은 시술을 통해 환자를 치료하는 확립된 임상적 방법론에 따라 선진적인 치료 옵션을 제공하는 여러 의료 기관이 마련되어 있습니다. 미국과 캐나다에서는 현재 더 나은 상환 제도와 보험 적용 범위가 확대되어 환자와 의료 기관이 직면한 경제적 장벽이 낮아짐에 따라 천골신경조절술의 치료 옵션으로서의 가용성과 경제적 타당성이 향상되고 있습니다. 주요 의료기기 제조업체의 존재와 신경 조절 시스템의 지속적인 기술 발전으로 배터리 수명 연장 및 고급 프로그래밍 기능을 갖춘 우수한 임플란트형 장치가 개발되었습니다. 이는 의사의 선택과 환자의 수용을 용이하게 하여 북미 시장에서의 매출 성장을 촉진하고 있습니다.

영문목차

Sacral Neuromodulation market size was valued at US$ 1,987.87 Million in 2024, expanding at a CAGR of 11.51% from 2025 to 2032.

Sacral neuromodulation (SNM) works as a medical treatment that uses electrical pulses to stimulate sacral nerves. The treatment restores normal nerve function by treating abnormal nerve signals that exist between the pelvic organs and the brain. Doctors use sacral neuromodulation to treat patients who suffer from overactive bladder and urinary urge incontinence, non-obstructive urinary retention, and fecal incontinence when patients do not respond to standard treatments, which include behavioral therapy and medications. The procedure starts with a testing phase, which monitors patient response through test stimulation, before doctors implant a permanent neurostimulator system in patients who demonstrate substantial symptom relief.

Sacral Neuromodulation Market- Market Dynamics

Increased awareness and improved reimbursement pathways

The sacral neuromodulation market experiences growth because two main factors drive its expansion, since better physician and patient education result in earlier diagnosis and increased acceptance of neuromodulation therapies to treat bladder and bowel disorders. The combinationof expanded clinical training programs with stronger clinical evidence and the inclusion of sacral neuromodulation in urology and gastroenterology treatment guidelines has increased physician confidence and referral rates. The combination of clear reimbursement frameworks with expanded insurance coverage in North America and selected European markets has decreased the financial expenses that patients need to pay for device implantation and subsequent treatment. The combination of enhanced awareness with better reimbursement systems has improved patient access to treatment, which results in faster adoption of sacral neuromodulation as standard therapy for refractory conditions and drives ongoing market growth.

Sacral Neuromodulation Market- Segmentation Analysis:

By Product Type

The Implantable Pulse Generators (IPGs) segment is expected to dominate the market over the forecast period. Sacral neuromodulation systems depend on IPGs which provide controlled electrical pulses that treat pelvic floor disorders through their direct connection to sacral nerves. The IPG devices serve as essential components for therapy operations which creates a direct link between their market demand and the adoption of sacral neuromodulation treatments that generate substantial revenue in the entire industry market. The ongoing development of technology through smaller device designs, extended battery operation, MRI compatibility, and programmable capabilities has made IPGs more beneficial for patients and doctors. The improvements lead to better patient comfort, which results in better clinical outcomes, and this effect increases both usage rates and product repurchases.

Sacral Neuromodulation Market- Geographical Insights

North America is expected to dominate the Sacral Neuromodulation market during the forecast period. The main reason for growth comes from the high occurrence of urinary and fecal incontinence, together with other pelvic floor disorders, which create a continuous need for effective neuromodulation treatments. The region enjoys benefits from its strong healthcare network, which provides multiple medical facilities that offer advanced treatment options and operate under established clinical methods for treating patients through procedures like sacral nerve stimulation. The United States and Canada now provide better reimbursement systems together with expanded insurance coverage, which reduces financial barriers that patients and healthcare facilities face, thereby increasing the availability and economic feasibility of sacral neuromodulation as a treatment option. The presence of major device manufacturers together with ongoing technological advancements in neuromodulation systems has led to the creation of better implantable devices that feature extended battery life and advanced programming functions, which help doctors choose these devices while patients become more willing to accept them, thus driving revenue growth in the North American market.

Sacral Neuromodulation Market- Competitive Landscape:

The sacral neuromodulation market functions through intense competition, which three major medtech companies Medtronic Axonics and Boston Scientific control while other established companies, including Abbott and various regional device manufacturers, compete. The market competition arises through three main factors which include technology differences that involve smaller MRI-safe rechargeable-free implantable pulse generators, better leads and programming software and the strength of distribution and clinical support, which helps doctors adopt new technologies. The current market environment results from legal and IP contests that have occurred between companies, while recent court decisions and active disputes have changed market competition and access. The market distribution keeps changing through ongoing product approvals, targeted M&A activities and strategic partnerships, while fast-growing Asian markets have become accessible for both agile competitors and local businesses to operate.

Recent Developments:

In June 2025, Neuspera(R) Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, announced that the U.S. Food and Drug Administration (FDA) has approved its integrated sacral neuromodulation (iSNM) system for the treatment of urinary urge incontinence (UUI).

In May 2025, Medtronic launched its next-generation InterStim X system featuring advanced wireless programming capabilities and extended battery life, significantly improving patient convenience and treatment outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SACRAL NEUROMODULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

BioControl Medical
Uroplasty Inc.
Cogentix Medical Inc.
Cyberonics Inc.
Nuvectra Corporation
Nevro Corp.
Synapse Biomedical Inc.
ImThera Medical Inc.
Abbott Laboratories
Advanced Bionics AG
Stryker Corporation
Inspire Medical Systems Inc.
Laborie Medical Technologies
MicroTransponder Inc.
Brainsway Ltd.
EndoStim Inc.
Stimwave LLC

GLOBAL SACRAL NEUROMODULATION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

External/Non-Implantable Pulse Generators (EPGs)
Lead Electrodes
Implantable Pulse Generators (IPGs)
Accessories and System Components

GLOBAL SACRAL NEUROMODULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Urinary Incontinence
Urinary Retention
Fecal Incontinence
Overactive Bladder
Chronic Pelvic Pain and Relative Pelvic Pain
Others

GLOBAL SACRAL NEUROMODULATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals and Large Medical Centers
Ambulatory Surgical Centers
Specialty Clinics
Research and Academic Institutes

GLOBAL SACRAL NEUROMODULATION MARKET, BY PATIENT AGE GROUP- MARKET ANALYSIS, 2019 - 2032

Adult
Pediatric
Geriatric

GLOBAL SACRAL NEUROMODULATION MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

Rechargeable Systems
Non-Rechargeable Systems
Wired/Lead Systems vs Wireless/Leadless Systems
Trial Systems vs Permanent Systems

GLOBAL SACRAL NEUROMODULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Sacral Neuromodulation Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Sacral Neuromodulation Market Snippet by Product Type
- 2.1.2. Sacral Neuromodulation Market Snippet by Application
- 2.1.3. Sacral Neuromodulation Market Snippet by End User
- 2.1.4. Sacral Neuromodulation Market Snippet by Patient Age Group
- 2.1.5. Sacral Neuromodulation Market Snippet by Technology
- 2.1.6. Sacral Neuromodulation Market Snippet by Country
- 2.1.7. Sacral Neuromodulation Market Snippet by Region
2.2. Competitive Insights

3. Sacral Neuromodulation Key Market Trends

3.1. Sacral Neuromodulation Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Sacral Neuromodulation Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Sacral Neuromodulation Market Opportunities
3.4. Sacral Neuromodulation Market Future Trends

4. Sacral Neuromodulation Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Sacral Neuromodulation Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Sacral Neuromodulation Market Landscape

6.1. Sacral Neuromodulation Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Sacral Neuromodulation Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. External/Non-Implantable Pulse Generators (EPGs)
- 7.1.3. Lead Electrodes
- 7.1.4. Implantable Pulse Generators (IPGs)
- 7.1.5. Accessories and System Components

8. Sacral Neuromodulation Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Urinary Incontinence
- 8.1.3. Urinary Retention
- 8.1.4. Fecal Incontinence
- 8.1.5. Overactive Bladder
- 8.1.6. Chronic Pelvic Pain and Relative Pelvic Pain
- 8.1.7. Others

9. Sacral Neuromodulation Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Hospitals and Large Medical Centers
- 9.1.3. Ambulatory Surgical Centers
- 9.1.4. Specialty Clinics
- 9.1.5. Research and Academic Institutes

10. Sacral Neuromodulation Market - By Patient Age Group

10.1. Overview
- 10.1.1. Segment Share Analysis, By Patient Age Group, 2024 & 2032 (%)
- 10.1.2. Adult
- 10.1.3. Pediatric
- 10.1.4. Geriatric

11. Sacral Neuromodulation Market - By Technology

11.1. Overview
- 11.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 11.1.2. Rechargeable Systems
- 11.1.3. Non-Rechargeable Systems
- 11.1.4. Wired/Lead Systems vs Wireless/Leadless Systems
- 11.1.5. Trial Systems vs Permanent Systems

12. Sacral Neuromodulation Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Sacral Neuromodulation Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Sacral Neuromodulation Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.18. Rest of Europe
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.18.6. Rest of the Europe Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.18.7. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Sacral Neuromodulation Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Sacral Neuromodulation Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Sacral Neuromodulation Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Sacral Neuromodulation Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. BioControl Medical
- 13.2.2. Uroplasty Inc.
- 13.2.3. Cogentix Medical Inc.
- 13.2.4. Cyberonics Inc.
- 13.2.5. Nuvectra Corporation
- 13.2.6. Nevro Corp.
- 13.2.7. Synapse Biomedical Inc.
- 13.2.8. ImThera Medical Inc.
- 13.2.9. Abbott Laboratories
- 13.2.10. Advanced Bionics AG
- 13.2.11. Stryker Corporation
- 13.2.12. Inspire Medical Systems Inc.
- 13.2.13. Laborie Medical Technologies
- 13.2.14. MicroTransponder Inc.
- 13.2.15. Brainsway Ltd.
- 13.2.16. EndoStim Inc.
- 13.2.17. Stimwave LLC

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us

한글목차

천골신경조절술 시장 : 세분화 분석

목차

제1장 천골신경조절술 시장 개요

제2장 주요 요약

제3장 천골신경조절술의 주요 시장 동향

제4장 천골신경조절술 시장 : 산업 분석

제5장 천골신경조절술 시장 : 높아지는 지정학적 긴장의 영향

제6장 천골신경조절술 시장 구도

제7장 천골신경조절술 시장 : 제품 종류별

제8장 천골신경조절술 시장 : 용도별

제9장 천골신경조절술 시장 : 최종사용자별

제10장 천골신경조절술 시장 : 환자 연령층별

제11장 천골신경조절술 시장 : 기술별

제12장 천골신경조절술 시장 : 지역별

제13장 주요 벤더 분석 : 천골신경조절술 산업

제14장 AnalystView의 전방위적 분석